REBECCA HOULIHAN: Open Payments
NPI 1639762594 · STRATHAM, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $468
Food & beverage: $373Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $95 |
| Organon LLC | 6 | $86 |
| UCB, Inc. | 2 | $54 |
| ABBVIE INC. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Galderma Laboratories, L.P. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Amgen Inc. | 1 | $21 |
| Incyte Corporation | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $15 |
Products named: TREMFYA, Bimzelx, SKYRIZI, Rhapsido, DUPIXENT, NEXPLANON, AKLIEF, OTEZLA.
Industry payments across NH — which companies pay providers there.
